June 14, 2018
1 min watch

ai4gi leads advance of GI artificial intelligence tools in new partnership

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

WASHINGTON — In this exclusive video perspective from Digestive Disease Week 2018, Healio Gastroenterology and Liver Disease spoke with Douglas K. Rex, MD, a gastroenterologist from Indiana University and advisory board chairman at ai4gi, regarding the codevelopment agreement between ai4gi and Olympus.

“These two companies coming together are going to create an opportunity that is going to be fantastic for endoscopy and for endoscopists,” Rex said. “I am very confident that they’re going to be able to develop some tools that are going to be tremendous to improve clinical decision-making during colonoscopies.”

To hear more about ai4gi, watch the video with company founder Michael Byrne, MD. To find out more about the partnership with Olympus, watch the video with group vice president Kurt Heine.

Disclosure: Rex reports he received consulting fees, grant or research support, or other financial benefits from Aries Pharmaceutical, Boston Scientific, Braintree, Colonary Solutions, Covidien/Medtronic, EndoAid Ltd, Olympus, Paion, and Sebela.